(S)-2-Amino-4-oxo-4-(tritylamino)butanoic acid hydrate is used as a key intermediate in the synthesis of antiviral and anticancer agents, particularly in the development of protease inhibitors. Its chiral (S) structure makes it valuable in asymmetric synthesis for pharmaceuticals. The trityl-protected amide side chain enables regioselective reactions in peptide synthesis, facilitating the construction of complex peptide structures. The protecting group can be removed with mild acid without damaging other peptide bonds. Commonly employed in solid-phase peptide synthesis and peptide modification to enhance stability and bioavailability. Also utilized in research for designing enzyme inhibitors due to its ability to mimic natural amino acid substrates like asparagine.